
Prometheus' Thiopurine metabolite testing helps physicians get patients to therapeutic goal and keep them there. Keeping patients’ 6-TGN levels within therapeutic goal increases the probability of a positive response and potentially reduces the need for concomitant medications. Thiopurine metabolite testing also helps identify some of the reasons for treatment failure. Prometheus' Thiopurine metabolites is covered by multiple patents.
For references see product information brochure.
Prometheus diagnostic services provide important information to aid in the diagnosis and management of certain diseases and conditions. How this information is used to guide patient care is the responsibility of the physician.